Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Medical Informatics

Date Submitted: Apr 26, 2024
Date Accepted: Aug 6, 2024

The final, peer-reviewed published version of this preprint can be found here:

Early Diagnosis of Hereditary Angioedema in Japan Based on a US Medical Dataset: Algorithm Development and Validation

Yamashita K, Nomoto Y, Hirose T, Yutani A, Okada A, Watanabe N, Suzuki K, Senzaki M, Kuroda T

Early Diagnosis of Hereditary Angioedema in Japan Based on a US Medical Dataset: Algorithm Development and Validation

JMIR Med Inform 2024;12:e59858

DOI: 10.2196/59858

PMID: 39270211

PMCID: 11437219

Early Diagnosis of Hereditary Angioedema Based on US Medical Dataset: Algorithm Development and Validation in Japan

  • Kouhei Yamashita; 
  • Yuji Nomoto; 
  • Tomoya Hirose; 
  • Akira Yutani; 
  • Akira Okada; 
  • Nayu Watanabe; 
  • Ken Suzuki; 
  • Munenori Senzaki; 
  • Tomohiro Kuroda

ABSTRACT

Background:

The rare genetic disease hereditary angioedema (HAE) induces acute attacks of swelling in various regions of the body. Its prevalence is estimated to be 1 in 50,000 people, with no reported bias among different ethnic groups. However, considering the estimated prevalence, the number of patients in Japan diagnosed with HAE remains approximately 1 in 250,000, which means that only 20% of potential HAE cases are identified.

Objective:

We aimed to develop an artificial intelligence (AI) model that can detect patients with suspected HAE using medical history data (medical claims, prescriptions, and EMR) in the US and validate the detection performance of HAE cases. We also aimed to verify whether the model was applicable to Japanese data.

Methods:

The HAE patient and control groups were identified from the US claims and EMR datasets. We analyzed the characteristics of the diagnostic history of patients with HAE and developed an AI model to predict the probability of HAE based on a generalized linear model and bootstrap method. The model was then applied to the EMR data of the Kyoto University Hospital to verify its applicability in Japanese data.

Results:

Precision and sensitivity were measured to validate the model performance. The precision score was 2% in the initial model-development step using the comprehensive US dataset. This means that while the prevalence of HAE is 1/50,000, our model can screen out suspected patients, where 1 in 50 of these patients actually have HAE. In addition, in the validation step with Japanese EMR data, the precision score was 23.6%, which exceeded our expectations. We achieved 61.5% sensitivity in the US and 37.6% in the validation in a single Japanese hospital. Overall, our model predicted patients with typical HAE symptoms.

Conclusions:

This study indicates that our AI model can detect HAE in patients with typical symptoms and is effective in Japanese data. However, further prospective clinical studies are required to investigate whether this model can be used to diagnose HAE.


 Citation

Please cite as:

Yamashita K, Nomoto Y, Hirose T, Yutani A, Okada A, Watanabe N, Suzuki K, Senzaki M, Kuroda T

Early Diagnosis of Hereditary Angioedema in Japan Based on a US Medical Dataset: Algorithm Development and Validation

JMIR Med Inform 2024;12:e59858

DOI: 10.2196/59858

PMID: 39270211

PMCID: 11437219

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.